secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXICURE, INC. (XCUR)
CIK:        0001698530
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001698530-23-000006
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 5.02, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Exicure receives Nasdaq delisting notice for board independence; director resigns
--------------------------------------------------------------------------------

- Jan 19, 2023: Nasdaq notifies Exicure of non-compliance with Listing Rule 5605 (independent director/audit committee requirements). Cure period ends at earlier of 2023 annual meeting or Dec 30, 2023.
- Director Jiyoung Hwang resigned effective Jan 16, 2023; no disagreement with company operations, policies, or practices.
- Company actively seeking qualified independent director to regain compliance; must comply by June 28, 2023 if annual meeting before that date.
- Private placement of 3,400,000 shares at $1.60/share with CBI USA expected to close by Feb 10, 2023 (previously disclosed Sep 26, 2022).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1698530/000169853023000006/0001698530-23-000006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1698530/000169853023000006/xcur-20230116.htm
  HTML page:      https://secwatch.observer/filing/0001698530-23-000006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer